Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-10 16:34 | 2024-12-06 | NOTV | Inotiv, Inc. | Harrington Michael J | Director | Services-Commercial Physical & Biological Research | BUY | $3.98 | 10,000 | $39,822 | 37,500 | +36.4% |
| 2024-08-27 00:05 | 2024-08-22 | ELAN | Elanco Animal Health Inc | Harrington Michael J | Director | Pharmaceutical Preparations | BUY | $14.85 | 3,500 | $51,974 | 81,094 | +4.5% |
| 2024-03-12 23:30 | 2024-03-08 | ELAN | Elanco Animal Health Inc | Harrington Michael J | Director | Pharmaceutical Preparations | BUY | $16.29 | 3,100 | $50,494 | 77,594 | +4.2% |
| 2021-12-03 01:16 | 2021-11-30 | ELAN | Elanco Animal Health Inc | Harrington Michael J | Director | Pharmaceutical Preparations | BUY | $29.25 | 2,500 | $73,123 | 28,164 | +9.7% |
| 2021-08-14 00:01 | 2021-08-11 | ELAN | Elanco Animal Health Inc | Harrington Michael J | Director | Pharmaceutical Preparations | BUY | $28.99 | 3,000 | $86,955 | 25,684 | +13.2% |
| 2020-03-12 00:34 | 2020-03-09 | ELAN | Elanco Animal Health Inc | Harrington Michael J | Director | Pharmaceutical Preparations | BUY | $23.84 | 4,000 | $95,360 | 16,799 | +31.3% |
| 2019-08-26 14:41 | 2019-04-22 | ELAN | Elanco Animal Health Inc | Harrington Michael J | Director | Pharmaceutical Preparations | BUY | $26.75 | 3,500 | $93,608 | 6,283 | +125.8% |
| 2019-06-04 20:57 | 2019-06-03 | LLY | ELI LILLY & Co | Harrington Michael J | Officer; Senior VP and General Counsel | Pharmaceutical Preparations | SALE | $116.72 | 16,000 | $1,867,520 | 110,300 | -12.7% |
| 2017-06-09 23:15 | 2017-06-09 | LLY | ELI LILLY & Co | Harrington Michael J | Officer; Senior VP and General Counsel | Pharmaceutical Preparations | SALE | $79.97 | 22,833 | $1,825,955 | 62,056 | -26.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.